Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long Term Follow up Study on Prevalence, Determinants, and the Effect of Years of Exposure

Background: Erythrocytosis is a known side effect of testosterone therapy in hypogonadal men and can increase the risk of thromboembolic events. Erythrocytosis is also seen in trans men (birth-assigned female, male gender identity) receiving testosterone therapy. Currently there are no clinical guid...

Descripción completa

Detalles Bibliográficos
Autores principales: Madsen, Milou Cecilia, van Dijk, Dennis, Wiepjes, Chantal, Conemans, Elfi, Thijs, Abel, Den Heijer, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Reproductive Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265838/
http://dx.doi.org/10.1210/jendso/bvab048.1477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265838/
http://dx.doi.org/10.1210/jendso/bvab048.1477

Ejemplares similares